|
Name of the product: AZATIOPRINA 50 DOSA
Active ingredient: Azathioprine 50 mg
Dosage form: tablets
Name of the product: AZATIOPRINA DOSA
Active ingredient: Azathioprine 100 mg
Dosage form: lyophilised injection
Dispensing requirements: Rx only
Argentine Industry
Composition:
AZATIOPRINA 50 DOSA tablets:
Each tablet contains azathioprine 50 mg, corn stach, lactose monohydrate, sodium croscarmellose, povidone, magnesium stearate, and sodium lauril sulphate.
AZATIOPRINA DOSA lyophilised injection:
Each glass bottle contains azathioprine 100 mg (as azathioprine sodium)
Indications:
AZATIOPRINA DOSA and AZATIOPRINA 50 DOSA are indicated as a complement for the prevention of rejection in renal homotransplantation; it is also indicated for the treatment of active rheumatoid arthritis that does not respond to the rest, aspirin, or any other non-esteroidal anti-inflammatory drugs, or that does not responds to any agents the same class, an example of which is the gold.
Therapeutic action:
Immunosuppressant.
Storage:
AZATIOPRINA 50 DOSA tablets:
Keep between 15º and 30º C in the marketed packing. Protect from the light.
AZATIOPRINA DOSA lyophilised injection:
Keep between 15º and 25º C in the marketed packing.
Marketed presentations:
AZATIOPRINA 50 DOSA tablets:
Packs containing 100 tablets.
Packs containing 500 tablets, for use in hospitals.
AZATIOPRINA DOSA lyophilised injection:
Packs containing 1 and 5 glass bottles.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 52116
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) Buenos Aires, Argentine
Pharmaceutical Director: María C. Terzo, Pharmacist
|
